Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation
Primary Purpose
Prolapse
Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Ultrasound Imaging
Sponsored by
About this trial
This is an interventional other trial for Prolapse
Eligibility Criteria
Inclusion Criteria:
- Current pessary users (> 6 months) who have no pessary related complication, including discomfort, repeated vaginal bleeding, and pessary extrusion
- Are able to provide informed consent
- Can perform self-care, i.e. removing and inserting the pessary themselves
- Are willing to remove their pessary 2 days before the ultrasound examination date.
Exclusion Criteria:
- Inability to give informed consent
- Inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
- History of pelvic radiation or surgery, (including hysterectomy)
- Using pessaries other than ring, incontinence dish, donut, Shaatz, Marland, or Gellhorn.
- Inability to perform the Valsalva maneuver or pelvic floor contraction
- Restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit.
- Lack of sensation at the pelvic floor.
- Being pregnant at the time of the examination.
Sites / Locations
- Victoria HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Patients with Pelvic Organ Prolapse
Arm Description
Patients who meet the inclusion criteria will be recruited. Ultrasound images of the pelvic floor and vaginal cavity will be analyzed to predict pessary size and type. This will be compared against the pessary size and type being used already by the patient.
Outcomes
Primary Outcome Measures
FEASIBILITY: The predicted pessary size
The predicted pessary size in cubic mm will be compared with the actual size of the pessary used by the patient
FEASIBILITY: The predicted pessary shape
The predicted pessary shape will be compared with the actual shape of the pessary used by the patient by calculating the DICE coefficient.
Secondary Outcome Measures
Full Information
NCT ID
NCT04099121
First Posted
May 1, 2019
Last Updated
August 9, 2022
Sponsor
Western University, Canada
Collaborators
Cosm Medical Corp.
1. Study Identification
Unique Protocol Identification Number
NCT04099121
Brief Title
Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation
Official Title
Evaluation of 3D Ultrasound Vaginal Manometry for Estimating the Optimal Pessary Size for Patients With Pelvic Organ Prolapse
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2020 (Actual)
Primary Completion Date
May 12, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Western University, Canada
Collaborators
Cosm Medical Corp.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Symptoms of female pelvic floor dysfunction, such as incontinence and pelvic organ prolapse, can be alleviated by using pessaries, which are passive medical devices that are inserted in the vagina to support the pelvic organs. Currently, pessaries are fit through trial and error after manual examination, the accuracy of which depends on the physician's expertise level.
The objective of this study is to evaluate the feasibility of using 3D translabial ultrasound imaging of the vagina at various distension volumes to predict the pessary size for successful fit. Ultrasound images will be obtained using commercially available 3D ultrasound probes (Philips, Netherlands), as well as a commercially available 2D ultrasound probe (Philips, Netherlands), which is linearly scanned to capture a 3D volume. The linear scanning will be performed by attaching the 2D probe to a motorized hand-held scanner, which is used to tilt and move the probe to acquire images. Please note that the hand-held scanner does not come in contact with the patient. To distend the vagina, a sterile bag is inserted in the vagina and gradually filled with water using a commercially available urodynamic system (Laborie, Canada) until the vaginal capacity is reached, without causing any discomfort to the patient. This image acquisition technique, previously reported in the literature, is referred to as 3D ultrasound vaginal manometry in this study.
To achieve the objective of this project, 35 pelvic organ prolapse patients, who (i) are current pessary users, (ii) can perform self-care of the pessary, and (iii) can provide informed consent, will be invited to participate in the study. Patients will be asked to remove their pessary prior to ultrasound imaging. Then, 3D ultrasound vaginal manometry will be performed, using the technique described above. Ultrasound images will be analyzed once data acquisition is completed. The size of the pessary estimated from ultrasound images will be compared with the actual pessary size used by the patient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prolapse
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Patients with Pelvic Organ Prolapse
Arm Type
Other
Arm Description
Patients who meet the inclusion criteria will be recruited. Ultrasound images of the pelvic floor and vaginal cavity will be analyzed to predict pessary size and type. This will be compared against the pessary size and type being used already by the patient.
Intervention Type
Device
Intervention Name(s)
Ultrasound Imaging
Intervention Description
3D ultrasound of the pelvic floor and vaginal cavity will be obtained by using a commercial ultrasound system.
Primary Outcome Measure Information:
Title
FEASIBILITY: The predicted pessary size
Description
The predicted pessary size in cubic mm will be compared with the actual size of the pessary used by the patient
Time Frame
Up to 3 months following data collection
Title
FEASIBILITY: The predicted pessary shape
Description
The predicted pessary shape will be compared with the actual shape of the pessary used by the patient by calculating the DICE coefficient.
Time Frame
Up to 3 months following data collection
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Pelvic organ prolapse only occurs in females.
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Current pessary users (> 6 months) who have no pessary related complication, including discomfort, repeated vaginal bleeding, and pessary extrusion
Are able to provide informed consent
Can perform self-care, i.e. removing and inserting the pessary themselves
Are willing to remove their pessary 2 days before the ultrasound examination date.
Exclusion Criteria:
Inability to give informed consent
Inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
History of pelvic radiation or surgery, (including hysterectomy)
Using pessaries other than ring, incontinence dish, donut, Shaatz, Marland, or Gellhorn.
Inability to perform the Valsalva maneuver or pelvic floor contraction
Restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit.
Lack of sensation at the pelvic floor.
Being pregnant at the time of the examination.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yvonne Leong, MD
Phone
519-685-8223
Email
yleong@uwo.ca
Facility Information:
Facility Name
Victoria Hospital
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5W9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yvonne Leong, MD
Email
Yvonne.Leong@lhsc.on.ca
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data will be de-identified, and only the aggregate results will be used for publication. Patient information will not be made public or shared with researchers outside of the study team.
Learn more about this trial
Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation
We'll reach out to this number within 24 hrs